Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Phys Chem Chem Phys ; 25(40): 27475-27487, 2023 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-37800275

RESUMO

The power conversion efficiencies of organic solar cells (OSCs) have been greatly improved in recent years. However, latest experimental data of high efficiency OSCs, the sublinear relationship between the short circuit current density (Jsc) and light intensity (Pin), and the effects of energetic disorder in bulk heterojunction organic solar cells have not been understood. An analytical model for high-efficiency OSCs is proposed, which takes most physical factors into account that have been ignored in most previous models, including practical solar spectra and absorption spectra, degeneracy effect, exciton effect, space charge limited current, and unified mobility expression dependent on temperature, electric field and density, etc. Three analytical iterative methods are proposed to solve the strong non-linear Poisson equation and the drift-diffusion equations. The method for the drift-diffusion equations involves introducing two constant coefficients and determining their values self-consistently by demanding the space averages of approximate drift and diffusion currents equal to the averages of accurate ones. The theoretical results for five high-efficiency OSCs are in good agreement with experimental data, including current-voltage curves, light intensity-dependent Jsc and open-circuit voltage (Voc) curves. The effects of energetic disorder in bulk heterojunction organic solar cells, and the sublinear relationship Jsc ∝ Pαin (α < 1) can be well explained. The Saha equation for exciton dissociation and the space-charge-limited-current (SCLC) effect are important for modelling high-efficiency OSCs. The Voc ∼ Pin relationship can be influenced by many factors. But, the Jsc ∼ Pin relationship can be mainly and slightly influenced by the exciton effect and energetic disorder, respectively. When aiming to realize higher performance OSCs, one should decrease six material parameters, including the energetic disorder, exciton mass, deep level impurity concentration, the ratios of electron and hole mobilities, densities of states for electrons and holes, and potential barriers at the anode and cathode. The performance parameters of 15 triad compounds are predicted by using ab initio Eg and absorption spectra from the literature along with other input parameters taken from previous optimized values, and the efficiency of two compounds was found to exceed 35%.

2.
Curr Cancer Drug Targets ; 20(8): 616-623, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32286946

RESUMO

BACKGROUND: Activation of the PI3K/mTOR signaling pathway plays a key role in the progression of human osteosarcoma. Studies have confirmed that VS-5584 was a novel inhibitor of the PI3K/mTOR pathway, and displayed potential anticancer activity. OBJECTIVE: To explore the anticancer effect and underlying mechanism of VS-5584 against the growth of human osteosarcoma cells. METHODS: U2OS and MG-63 human osteosarcoma cells were cultured and the cytotoxicity, cell apoptosis in VS-5584-treated cells were explored by the CCK8 assay, flow cytometric analysis and western blot. Cell migration and tube formation were also employed to examine the anticancer potential. RESULTS: The results showed that VS-5584 treatment dose-dependently inhibited the growth of U2OS and MG-63 cells by induction of G1-phase arrest through regulating p21, p27, Cyclin B1 and Cdc2. Further investigation revealed that VS-5584 treatment effectively inhibited the PI3K/mTOR signaling pathway and triggered MAPK phosphorylation. Moreover, VS-5584 treatment dramatically suppressed cell migration and tube formation of HUVECs, followed by the down-regulation of HIF-1α and VEGF. CONCLUSION: Our findings validated that VS-5584 may be a promising anticancer agent with potential application in the chemotherapy and chemoprevention of human osteosarcoma.


Assuntos
Pontos de Checagem da Fase G1 do Ciclo Celular/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Morfolinas/farmacologia , Osteossarcoma/tratamento farmacológico , Fosfatidilinositol 3-Quinase/química , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Purinas/farmacologia , Apoptose , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/metabolismo , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/genética , Neoplasias Ósseas/metabolismo , Neoplasias Ósseas/patologia , Proliferação de Células , Humanos , Osteossarcoma/genética , Osteossarcoma/metabolismo , Osteossarcoma/patologia , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA